| Literature DB >> 28772831 |
Wei Zhang1, Xuhui She2,3, Liping Wang4,5, Huajun Fan6, Qing Zhou7, Xiaowen Huang8, James Z Tang9.
Abstract
A novel molecular imprintingEntities:
Keywords: drug release; itaconic acid; molecularly imprinted polymer; serum analysis; sulpiride
Year: 2017 PMID: 28772831 PMCID: PMC5459076 DOI: 10.3390/ma10050475
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Optimization of the molecularly imprinted polymer (MIP) formulations against the adsorption capacity of the MIP and the non-imprinted polymer (NIP): (a) itaconic acid (ITA); (b) ethylene glycol dimethacrylate (EGDMA); (c) azoisobutyronitrile (AIBN); and (d) methanol.
Figure 2Fourier Transform Infrared (FT-IR) spectra of the MIP and the NIP: (a) sulpiride; (b) MIP with sulpiride; (c) NIP; and (d) MIP.
Figure 3Scanning electron micrographs of: the MIP (a); and the NIP (b).
Figure 4The adsorption isotherms of the MIP and the NIP (a); and Scatchard profile of the MIP (b).
Figure 5Kinetic adsorption curves of the MIP and NIP to sulpiride.
Selective adsorption of the MIP to sulpiride and its analogs.
| Substrate | Chemical Structure | Specific Adsorption Ratio (%) | Imprinting Factor, | Specific Factor, | |||
|---|---|---|---|---|---|---|---|
| Sulpiride | 60.05 | 11.20 | 48.85 | 81.35 | 5.36 | 1.00 | |
| Amisulpride | 55.00 | 15.10 | 39.90 | 72.55 | 3.64 | 0.82 | |
| Tiapride | 50.35 | 15.55 | 34.80 | 69.12 | 3.24 | 0.71 | |
| Lidocaine | 25.75 | 6.60 | 19.15 | 74.37 | 3.90 | 0.39 | |
| Cisapride | 18.50 | 6.55 | 11.95 | 64.59 | 2.82 | 0.24 |
The results of selective adsorption of the MIP to p-toluenesulfonamide, formamide and 1-methylpyrrolidine
| Substrate | Chemical Structure | Specific Adsorption Ratio (%) | Imprinting Factor, | |||
|---|---|---|---|---|---|---|
| p-Toluenesulfonamide | 0.51 | 0.01 | 0.50 | 98.04 | – | |
| Formamide | 7.53 | 2.51 | 5.02 | 66.67 | 3.01 | |
| 1-Methylpyrrolidine | 85.01 | 62.46 | 22.55 | 26.52 | 1.36 |
Figure 6The formation process of imprinting cavity of the MIP with sulpiride.
The results of solid-phase extraction of different compounds with the MIP.
| Substrate | Chemical Structure | Recovery (%) | Specific Factor, | ||
|---|---|---|---|---|---|
| Sulfamethoxazole | 0 | 0 | 0 | 0 | |
| Sulfanilamide | 0.21 | 0.03 | 2.10 | 0.03 | |
| p-Toluenesulfonamide | 0 | 0 | 0 | 0 | |
| p-Nitroaniline | 0.24 | 0.13 | 2.39 | 0.02 | |
| Acetanilide | 0 | 0 | 0 | 0 | |
| Trimethoprim | 6.43 | 3.26 | 64.3 | 0.52 | |
| Sulpiride | 8.39 | 2.28 | 86.9 | 1.00 |
Figure 7HPLC chromatograms of the mixed solution (1 μmol/L): before (a); and the eluent after solid-phase extraction (SPE) with the MIP (b); and after SPE with the NIP (c). 1: sulfamethoxazole; 2: sulfanilamide; 3: p-toluenesulfonamide; 4: p-nitroaniline; 5: acetanilide; 6: trimethoprim; 7: sulpiride.
Figure 8The HPLC chromatograms of: rat serum blank (a); rat serum sample after SPE with the MIP (b); and standard solution of sulpiride at 0.100 µmol/L (c).
The results of solid-phase extraction of sulpiride from rat serum samples by the MIP (n = 3).
| Sample | Spike Levels (μmol/L) | Determined (μmol/L) | Recovery (%) |
|---|---|---|---|
| 1 | 0.050 | 0.432 ± 0.005 | 86.63 ± 0.75 |
| 2 | 0.100 | 0.862 ± 0.038 | 86.23 ± 3.75 |
| 3 | 0.150 | 1.223 ± 0.041 | 81.57 ± 2.73 |
Figure 9Release curves of: MIP–sulpiride in the different pH media (a); and sulpiride tablets with and without MIP (b).